Sale!

SFXN4 Gene Combined oxidative phosphorylation deficiency type 18 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The SFXN4 Gene Combined Oxidative Phosphorylation Deficiency Type 18 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE. This test focuses on identifying mutations in the SFXN4 gene, which are linked to Combined Oxidative Phosphorylation Deficiency Type 18, a rare genetic disorder that affects mitochondrial function. This condition can lead to a wide range of clinical symptoms, including muscle weakness, neurological impairment, and systemic energy metabolism issues.

The test employs advanced genetic sequencing techniques to analyze the SFXN4 gene, providing crucial information for the accurate diagnosis and potential management of the disorder. The cost of the test is 4400 AED, reflecting the comprehensive analysis and detailed insights it provides into the patient’s genetic makeup. By identifying specific genetic mutations, healthcare providers can better understand the condition’s progression and explore targeted treatment options, offering hope for affected individuals and their families. DNA Labs UAE, known for its state-of-the-art facilities and expert team, ensures high-quality testing and reliable results for patients undergoing this genetic assessment.

Description

SFXN4 Gene Combined Oxidative Phosphorylation Deficiency Type 18 Genetic Test

Welcome to DNA Labs UAE, where we offer the SFXN4 gene combined oxidative phosphorylation deficiency type 18 genetic test. This test is designed to diagnose individuals with a disorder characterized by a deficiency in the process of oxidative phosphorylation. Read on to learn more about the test and its components.

Test Details

The SFXN4 gene is associated with a disorder called combined oxidative phosphorylation deficiency type 18. This disorder is characterized by a deficiency in the process of oxidative phosphorylation, which is responsible for producing energy in the form of adenosine triphosphate (ATP) in cells.

The NGS genetic test for combined oxidative phosphorylation deficiency type 18 analyzes the SFXN4 gene to identify any genetic mutations or variations that may be causing the disorder. This test can help diagnose individuals with the condition and provide valuable information for treatment and management.

NGS stands for next-generation sequencing, which is a high-throughput method used to analyze multiple genes simultaneously. This allows for a comprehensive analysis of the SFXN4 gene and other relevant genes, increasing the chances of identifying any genetic abnormalities.

Overall, the NGS genetic test for combined oxidative phosphorylation deficiency type 18 can help in the diagnosis and management of individuals with this disorder, providing important information for personalized treatment plans.

Test Components and Price

Test Name: SFXN4 Gene Combined Oxidative Phosphorylation Deficiency Type 18 Genetic Test
Price: 4400.0 AED

Sample Condition

The test can be performed using blood, extracted DNA, or one drop of blood on an FTA card.

Report Delivery

The test report will be delivered within 3 to 4 weeks.

Method

The test utilizes NGS technology for analysis.

Test Type

The SFXN4 Gene Combined Oxidative Phosphorylation Deficiency Type 18 Genetic Test falls under the category of metabolic disorders.

Referring Doctor

The referring doctor for this test is a General Physician.

Test Department

The test is conducted in our Genetics department.

Pre Test Information

Prior to the test, it is important to provide the clinical history of the patient who is going for the SFXN4 gene combined oxidative phosphorylation deficiency type 18 NGS genetic DNA test. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected with combined oxidative phosphorylation deficiency type 18.

For more information or to schedule an appointment, please contact DNA Labs UAE.

Test Name	SFXN4 Gene Combined oxidative phosphorylation deficiency type 18 Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Metabolic Disorders
Doctor	General Physician
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for SFXN4 Gene Combined oxidative phosphorylation deficiency type 18 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Combined oxidative phosphorylation deficiency type 18
Test Details	The SFXN4 gene is associated with a disorder called combined oxidative phosphorylation deficiency type 18. This disorder is characterized by a deficiency in the process of oxidative phosphorylation, which is responsible for producing energy in the form of adenosine triphosphate (ATP) in cells. The NGS genetic test for combined oxidative phosphorylation deficiency type 18 analyzes the SFXN4 gene to identify any genetic mutations or variations that may be causing the disorder. This test can help diagnose individuals with the condition and provide valuable information for treatment and management. NGS stands for next-generation sequencing, which is a high-throughput method used to analyze multiple genes simultaneously. This allows for a comprehensive analysis of the SFXN4 gene and other relevant genes, increasing the chances of identifying any genetic abnormalities. Overall, the NGS genetic test for combined oxidative phosphorylation deficiency type 18 can help in the diagnosis and management of individuals with this disorder, providing important information for personalized treatment plans.

Browse

Want to chat?

Social